Results 81 to 90 of about 4,104 (188)

Biophysical Approach to Understand Life and Cancer

Aging and Cancer, Volume 5, Issue 3, Page 70-90, September 2024.
ABSTRACT Background From the perspective of biology, the characteristics of life can be categorized as cellular organizations, homeostasis, metabolism, growth, reproduction and heredity, response to stimuli and adaptation to the environment. From the perspective of physics, living organisms are highly ordered, complex, thermodynamically open systems ...
Nuri Faruk Aykan
wiley   +1 more source

Pasireotide: a novel treatment for patients with acromegaly

Drug Design, Development and Therapy, 2016
Daniel Cuevas-Ramos,1 Maria Fleseriu2,3 1Department of Endocrinology and Metabolism, Neuroendocrinology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; 2Department of Medicine ...
Cuevas-Ramos D, Fleseriu M
doaj  

Pasireotide Long‐Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism

Journal of Veterinary Internal Medicine, 2017
Background Long‐term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel somatostatin analogue, decreases serum insulin‐like growth factor 1 (IGF‐1) and improves insulin sensitivity in cats with HS when ...
R. Gostelow, C. Scudder, S. Keyte, Y. Forcada, R.C. Fowkes, H.A. Schmid, D.B. Church, S.J.M. Niessen   +7 more
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

A single-surgeon series of 93 patients undergoing pancreatectomy with pasireotide for prevention of pancreatic fistula [PDF]

, 2021
C.B. Polen, L.M. Ebbit, Prakash K. Pandalai, J. Kim, Michael J. Cavnar   +4 more
openalex   +1 more source

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas [PDF]

, 2017
Federico Gatto, Richard A. Feelders, Sanne Franck, Peter M. van Koetsveld, Fadime Dogan, Johan M. Kros, Sebastian Neggers, Aart‐Jan van der Lely, Steven W. J. Lamberts, Diego Ferone, Leo J. Hofland   +10 more
openalex   +1 more source

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial [PDF]

, 2017
Matthew H. Kulke, Philippe Ruszniewski, Eric Van Cutsem, Catherine Lombard‐Bohas, Juan W. Valle, Wouter W. de Herder, Marianne Pavel, Evgeny Degtyarev, Jan C. Brase, Lida Bubuteishvili‐Pacaud, Maurizio Voi, Ramón Salazar, Ivan Borbath, Nicola Fazio, Denis Smith, Jaume Capdevila, Rachel P. Riechelmann, Jin‐Guang Yao   +17 more
openalex   +1 more source

Acromegaly: Beyond surgery

Indian Journal of Endocrinology and Metabolism, 2013
Acromegaly is characterized by chronic, excess secretion of growth hormone (GH) from a pituitary adenoma, and elevated hepatic insulin-like growth factor 1 (IGF-1) levels.
Gaya Thanabalasingham, Ashley B Grossman
doaj   +1 more source

The role of pasireotide in developing clinically significant pancreatic fistula [PDF]

, 2019
Jorge Matute
openalex   +1 more source

Clinical use of pasireotide for Cushing's disease in adults

Therapeutics and Clinical Risk Management, 2015
Filippo Ceccato, Carla Scaroni, Marco Boscaro Endocrinology Unit, Department of Medicine, Padova University Hospital, Padova, Italy Cushing’s disease: Excessive corticotroph hormone levels sustained by an adrenocorticotropic hormone-secreting ...
Ceccato F, Scaroni C, Boscaro M
doaj